Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norfolk Southern Corporation (NSC) vs GeneDx Holdings Corp (WGS) Price & Performance

Norfolk Southern CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Norfolk Southern Corporation vs GeneDx Holdings Corp — how do they compare? Norfolk Southern Corporation trades at $335.84 (market cap $75.15B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Norfolk Southern Corporation is far larger — about 30.8× GeneDx Holdings Corp's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

NSCWGS
Market Cap
$75.15B$2.44B
Sector
TechnologyTechnology
52-Week High
$350.66$167.51
52-Week Low
$272.35$34.51
Enterprise Value
$90.70B$2.48B
Dividend Yield
1.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Norfolk Southern Corporation

Norfolk Southern (NSC) trades at $335.41, up 0.44% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $369.67. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $3.52 exceeding expectations, driven by record revenue and volume growth. A pending merger with Union Pacific and a recent dividend declaration highlight ongoing corporate activity.

The outlook is positive, supported by strong operational performance and favorable industry trends, though risks include integration challenges from the merger, premium valuation metrics, and potential economic headwinds affecting freight demand. Investor sentiment is mixed, with analysts predominantly holding a neutral to bullish stance.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.

Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Norfolk Southern Corporation

Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.

Read more on NSC

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS